Reported Earlier, ProKidney Prices Upsized $130M Public Offering Of 53,719,009 Class A Ordinary Shares At $2.42/Share And Concurrent Registered Direct Offering
Portfolio Pulse from Benzinga Newsdesk
ProKidney has announced an upsized public offering of $130 million, involving 53,719,009 Class A ordinary shares priced at $2.42 per share. The offering is expected to close around June 13, 2024, pending customary closing conditions.
June 12, 2024 | 6:25 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ProKidney has announced an upsized public offering of $130 million, involving 53,719,009 Class A ordinary shares priced at $2.42 per share. The offering is expected to close around June 13, 2024, pending customary closing conditions.
The announcement of a public offering typically leads to a short-term decrease in stock price due to dilution of existing shares. The offering is substantial at $130 million and involves a significant number of shares, which could put downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100